514 related articles for article (PubMed ID: 10201999)
41. Human LT-alpha-mediated resistance to autoimmune diabetes is induced in NOD, but not NOD-scid, mice and abrogated by IL-12.
Miyaguchi S; Satoh J; Takahashi K; Sakata Y; Nakazawa T; Miyazaki J; Toyota T
Clin Immunol; 2001 Jan; 98(1):119-24. PubMed ID: 11141334
[TBL] [Abstract][Full Text] [Related]
42. High density insulin receptor-positive T lymphocytes from nonobese diabetic mice transfer insulitis and diabetes.
McInerney MF; Flynn JC; Goldblatt PJ; Najjar SM; Sherwin RS; Janeway CA
J Immunol; 1996 Oct; 157(8):3716-26. PubMed ID: 8871675
[TBL] [Abstract][Full Text] [Related]
43. The role of CD8+ T cells in the initiation of insulin-dependent diabetes mellitus.
Wang B; Gonzalez A; Benoist C; Mathis D
Eur J Immunol; 1996 Aug; 26(8):1762-9. PubMed ID: 8765018
[TBL] [Abstract][Full Text] [Related]
44. Effects of insulin like growth factor-1 and insulin on effector T cells generating autoimmune diabetes.
Bergerot I; Fabien N; Thivolet C
Diabetes Metab; 1996 Jul; 22(4):235-9. PubMed ID: 8767168
[TBL] [Abstract][Full Text] [Related]
45. CD8 cytotoxic T-cell clone rapidly transfers autoimmune diabetes in very young NOD and MHC class I-compatible scid mice.
Yoneda R; Yokono K; Nagata M; Tominaga Y; Moriyama H; Tsukamoto K; Miki M; Okamoto N; Yasuda H; Amano K; Kasuga M
Diabetologia; 1997 Sep; 40(9):1044-52. PubMed ID: 9300241
[TBL] [Abstract][Full Text] [Related]
46. Contribution of T cells to the development of autoimmune diabetes in the NOD mouse model.
Toyoda H; Formby B
Bioessays; 1998 Sep; 20(9):750-7. PubMed ID: 9819564
[TBL] [Abstract][Full Text] [Related]
47. Differential activities of secreted lymphotoxin-alpha3 and membrane lymphotoxin-alpha1beta2 in lymphotoxin-induced inflammation: critical role of TNF receptor 1 signaling.
Sacca R; Cuff CA; Lesslauer W; Ruddle NH
J Immunol; 1998 Jan; 160(1):485-91. PubMed ID: 9552007
[TBL] [Abstract][Full Text] [Related]
48. Immunotargeting of insulin reactive CD8 T cells to prevent diabetes.
Scott GS; Fishman S; Khai Siew L; Margalit A; Chapman S; Chervonsky AV; Wen L; Gross G; Wong FS
J Autoimmun; 2010 Dec; 35(4):390-7. PubMed ID: 20850948
[TBL] [Abstract][Full Text] [Related]
49. IL-1alpha, IL-1beta, and IFN-gamma mark beta cells for Fas-dependent destruction by diabetogenic CD4(+) T lymphocytes.
Amrani A; Verdaguer J; Thiessen S; Bou S; Santamaria P
J Clin Invest; 2000 Feb; 105(4):459-68. PubMed ID: 10683375
[TBL] [Abstract][Full Text] [Related]
50. Analysis of action mechanism of lymphotoxin in prevention of cyclophosphamide-induced diabetes in NOD mice.
Takahashi K; Satoh J; Sagara M; Zhu XP; Muto G; Muto Y; Fukuzawa M; Nishimura S; Miyaguchi S; Toyata T
J Autoimmun; 1995 Jun; 8(3):335-46. PubMed ID: 7575995
[TBL] [Abstract][Full Text] [Related]
51. Protection of NIT-1 pancreatic beta-cells from immune attack by inhibition of NF-kappaB.
Stephens LA; Thomas HE; Kay TW
J Autoimmun; 1997 Jun; 10(3):293-8. PubMed ID: 9218757
[TBL] [Abstract][Full Text] [Related]
52. The pro-apoptotic BH3-only protein Bid is dispensable for development of insulitis and diabetes in the non-obese diabetic mouse.
Mollah ZU; Wali J; McKenzie MD; Krishnamurthy B; Graham KL; Fynch S; Szanyi J; Santamaria P; Brodnicki T; Allison J; Strasser A; Kay TW; Thomas HE
Apoptosis; 2011 Aug; 16(8):822-30. PubMed ID: 21644000
[TBL] [Abstract][Full Text] [Related]
53. Suppressor of cytokine signaling-1 overexpression protects pancreatic beta cells from CD8+ T cell-mediated autoimmune destruction.
Chong MM; Chen Y; Darwiche R; Dudek NL; Irawaty W; Santamaria P; Allison J; Kay TW; Thomas HE
J Immunol; 2004 May; 172(9):5714-21. PubMed ID: 15100317
[TBL] [Abstract][Full Text] [Related]
54. Genetic requirements for acceleration of diabetes in non-obese diabetic mice expressing interleukin-2 in islet beta-cells.
Allison J; McClive P; Oxbrow L; Baxter A; Morahan G; Miller JF
Eur J Immunol; 1994 Oct; 24(10):2535-41. PubMed ID: 7925581
[TBL] [Abstract][Full Text] [Related]
55. Complete Freund's adjuvant-induced T cells prevent the development and adoptive transfer of diabetes in nonobese diabetic mice.
Qin HY; Sadelain MW; Hitchon C; Lauzon J; Singh B
J Immunol; 1993 Mar; 150(5):2072-80. PubMed ID: 8436836
[TBL] [Abstract][Full Text] [Related]
56. IL-10 impacts autoimmune diabetes via a CD8+ T cell pathway circumventing the requirement for CD4+ T and B lymphocytes.
Balasa B; Davies JD; Lee J; Good A; Yeung BT; Sarvetnick N
J Immunol; 1998 Oct; 161(8):4420-7. PubMed ID: 9780221
[TBL] [Abstract][Full Text] [Related]
57. CD4+ CD25+ regulatory T cells prevent type 1 diabetes preceded by dendritic cell-dominant invasive insulitis by affecting chemotaxis and local invasiveness of dendritic cells.
Lee MH; Lee WH; Todorov I; Liu CP
J Immunol; 2010 Aug; 185(4):2493-501. PubMed ID: 20639483
[TBL] [Abstract][Full Text] [Related]
58. CD8+ T cell homing to the pancreas in the nonobese diabetic mouse is CD4+ T cell-dependent.
Thivolet C; Bendelac A; Bedossa P; Bach JF; Carnaud C
J Immunol; 1991 Jan; 146(1):85-8. PubMed ID: 1670607
[TBL] [Abstract][Full Text] [Related]
59. In vivo expression of perforin by CD8+ lymphocytes in autoimmune disease. Studies on spontaneous and adoptively transferred diabetes in nonobese diabetic mice.
Young LH; Peterson LB; Wicker LS; Persechini PM; Young JD
J Immunol; 1989 Dec; 143(12):3994-9. PubMed ID: 2480383
[TBL] [Abstract][Full Text] [Related]
60. Apoptosis and beta-cell destruction in pancreatic islets of NOD mice with spontaneous and cyclophosphamide-accelerated diabetes.
Augstein P; Elefanty AG; Allison J; Harrison LC
Diabetologia; 1998 Nov; 41(11):1381-8. PubMed ID: 9833948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]